Beyond Minoxidil: Why KilgourMD Is Taking a Different Approach to Women’s Hair Thinning

Half of women over 50 will experience visible hair thinning – yet the most common treatments, including minoxidil, weren’t designed around the biology of aging women’s hair. Keep reading to explore the hidden flaws in standard treatments, why aging scalps require a new approach, and what sets KilgourMD’s two-step serum apart – or jump straight to the clinical results and final thoughts.

The problem: treatments that don’t address women’s needs

When minoxidil was approved by the FDA in 1988, the research behind it was overwhelmingly male. The drug, which was originally a blood pressure medication, was repurposed after male patients reported unexpected hair growth. While a women’s formulation came later, the dose is lower, yet the side effects are worse.

The three real causes of hair loss in women after 40

The missing piece: your scalp is aging, too

When scalp skin ages – through hormonal depletion, UV oxidative stress, and simple biology – follicles shrink, their growth cycles shorten, and hairs that do emerge are finer, shorter-lived, and increasingly sparse. Washing your hair with a “thickening” shampoo does nothing to reverse this. Neither does taking high amounts of biotin.

This is the foundation behind KilgourMD’s approach. By targeting the aging scalp with a science-backed formula designed around addressing the main causes for women, KilgourMD takes a different approach to supporting stronger, healthier-looking hair from the root.

What sets KilgourMD’s serum apart 

The most effective approach to scalp health mirrors what decades of clinical dermatology have established for facial skin: prevent the damage first, then treat what has already occurred.

KilgourMD’s system works in two steps – a Prevention Serum that acts like an antioxidant “SPF” for the scalp, neutralizing oxidative stress and blocking DHT before damage sets in; and a Treatment Serum that stimulates follicle stem cells, activating growth in follicles that have already begun to miniaturize. Applied like a skincare serum directly on the scalp (no rinsing required!), the system integrates naturally into your routine —with visible results in as little as 6 weeks.

The clinical numbers behind KilgourMD’s solution

Three of the actives in KilgourMD’s Treatment Serum — Redensyl, Capixyl and Procapil — have been trialled directly against 5% minoxidil. Researchers judged that 64.7% of the people using the three-ingredient combination had visibly improved, against 25.5% of those on minoxidil.

The studies measured real-world shedding markers, including hair loss during brushing and wash days – often the first signs women notice worsening. By week six, 95% of users saw a noticeable decrease in hair fall.* The 2025 clinical trial reported no serious side effects – a meaningful contrast to conventional treatments, where side-effect burden is a primary reason women stop.

Final Thoughts

Hair loss in women after 40 is a scalp problem. It starts with DHT acting on an aging, oxidatively-stressed follicle environment, and it requires a solution that addresses that environment directly, not one that arrived via a men’s clinical trial or a vitamin capsule.

KilgourMD was built from the simple observation that millions of women were being failed by a category that had barely noticed them. Science catches up when someone decides to look. If you’re ready to take a targeted approach to thinning hair and support healthier growth from the scalp up, KilgourMD is worth trying.